[1]
|
Banting, F.M. and Best, C.H. (1922) The internal secretion of the pancreas. Journal of Laboratory and Clinical Medicine, 7, 256-271
|
[2]
|
Buse, J.B., Polonsky, K.S. and Burant, C.F. (2008) Type 2 diabetes mellitus. In: Kronenberg, H.M., Melmed, S., Polanski, K.S., Larsen and P.R., Eds., Williams Textbook of Endocrinology, 11th Edition, Saunders Elsevier, Philadelphia, 1329-1389.
|
[3]
|
Yki-Javimen, H., Kaupilla, M., Kujansuu, E., et al. (1992) Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. New England Journal of Medicine, 327, 1426-1433.
doi:10.1056/NEJM199211123272005
|
[4]
|
Warram, J.H., Martin, B.C., Krowelski, A.S., et al. (1990) Slow glucose removal and hyperinsulinemia precede the development of type 2 diabetes in the offspring of diabetic parents. Annals of Internal Medicine, 113, 909-915.
|
[5]
|
Cheng, Y.Y.A. and Zinman, B. (2010) Principles of Insulin Therapy. In: Khan, C.R., Weir, G.C., King, G.L., Jacobson, A.M., Moses, A.C. and Smith, R.J., Eds. Joslin’s Diabetes Mellitus, 14th Edition, Wolters Kluwer(India) Pvt Ltd, New Delhi, 659-670.
|
[6]
|
The Diabetes Control and Complications Research Group (1995) Adverse events and their association with treatment regimens in the diabetes control and complications trial. Diabetes Care, 18, 1415-1427.
doi:10.2337/diacare.18.11.1415
|
[7]
|
UKPDS group (1998) intensive blood glucose control with sulphonulureasor insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837-853.
|
[8]
|
Field, J.B. (1970) Chronic insuli resistance. Acta Diabetologica, 7, 220-242. doi:10.1007/BF01556784
|
[9]
|
Inoguchi, T., Xia, P., Kunisaki, M., et al. (1994) insulin effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. American Journal of Physiology, 267, E369-E379.
|
[10]
|
Fonseca, V., Graveline, J. and Nissel, J. (1998) Long term experience with troglitazone in combination with insulin type 2 diabetes mellitus. Diabetes, 47, A90(abt).
|
[11]
|
Relimpio, F., Pumer, A., Losado, F., et al. (1998) Adding metformin versus insulin dose increase in insulin treated but poorly controlled type2 diabetes mellitus. An open label randomized trial. Diabetic Medicine, 15, 997-1002.
|
[12]
|
Schwartz, S., Raskin, P., Fonsec, V., et al. (1998) Effect of troglitazone in insulin-treated patients with type 2 diabetes mellitus. New England Journal of Medicine, 338, 861-866. doi:10.1056/NEJM199803263381302
|
[13]
|
Henry, R.R. (1996) Glucose control and insulin resistance in non-insulin dependent diabetes mellitus. Annals of Internal Medicine, 124, 97-103.
|
[14]
|
Bailey, C.J. Metformin in therapy for diabetes mellitus and related disorders. 5th Edition, ADA, 235-253.
|
[15]
|
Lebovitz, H.E. Thiazolidinedione in therapy for diabetes mellitus and related disorders. 5th Edition, ADA, 260-272.
|
[16]
|
Torbay, N., Bracco, E., Geliebter, A., et al. (1985) Insulin increases body fat despite control of food intake and physical activity. American Journal of Physical, 258, R2120-R2144.
|